ATE204757T1 - Verwendung von piperine zur verbesserung der gastrointestinalen absorption - Google Patents

Verwendung von piperine zur verbesserung der gastrointestinalen absorption

Info

Publication number
ATE204757T1
ATE204757T1 AT95939489T AT95939489T ATE204757T1 AT E204757 T1 ATE204757 T1 AT E204757T1 AT 95939489 T AT95939489 T AT 95939489T AT 95939489 T AT95939489 T AT 95939489T AT E204757 T1 ATE204757 T1 AT E204757T1
Authority
AT
Austria
Prior art keywords
piperine
gastrointestinal absorption
compositions
improve gastrointestinal
nutrients
Prior art date
Application number
AT95939489T
Other languages
English (en)
Inventor
Muhammed Majeed
Vladimir Badmaev
R Jayanagar Eastend Rajendran
Original Assignee
Sabinsa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27014435&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE204757(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/393,738 external-priority patent/US5536506A/en
Application filed by Sabinsa Corp filed Critical Sabinsa Corp
Application granted granted Critical
Publication of ATE204757T1 publication Critical patent/ATE204757T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
    • A23L27/11—Natural spices, flavouring agents or condiments; Extracts thereof obtained by solvent extraction
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
AT95939489T 1995-02-24 1995-11-06 Verwendung von piperine zur verbesserung der gastrointestinalen absorption ATE204757T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/393,738 US5536506A (en) 1995-02-24 1995-02-24 Use of piperine to increase the bioavailability of nutritional compounds
US08/550,496 US5744161A (en) 1995-02-24 1995-10-30 Use of piperine as a bioavailability enhancer
PCT/US1995/012758 WO1996025939A1 (en) 1995-02-24 1995-11-06 Use of piperine as a bioavailability enhancer

Publications (1)

Publication Number Publication Date
ATE204757T1 true ATE204757T1 (de) 2001-09-15

Family

ID=27014435

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95939489T ATE204757T1 (de) 1995-02-24 1995-11-06 Verwendung von piperine zur verbesserung der gastrointestinalen absorption

Country Status (12)

Country Link
US (2) US5744161A (de)
EP (1) EP0810868B1 (de)
JP (1) JP3953513B2 (de)
AT (1) ATE204757T1 (de)
AU (1) AU4128796A (de)
CA (1) CA2247467C (de)
DE (1) DE69522477T2 (de)
DK (1) DK0810868T3 (de)
ES (1) ES2161914T3 (de)
GR (1) GR3036711T3 (de)
PT (1) PT810868E (de)
WO (1) WO1996025939A1 (de)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352713B1 (en) * 1999-12-01 2002-03-05 Drugtech Corporation Nutritional composition
US6488956B1 (en) * 1994-06-20 2002-12-03 Drugtech Corporation Multi-vitamin and mineral supplements for women
US5744161A (en) * 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer
US6060060A (en) * 1997-01-31 2000-05-09 Bmb Patent Holding Corporation Analgesic compositions from sweet peppers and methods of use thereof
US5962030A (en) 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
ATE304364T1 (de) 1997-08-08 2005-09-15 Nutrition 21 Chromium/biotin behandlung von typ-ii diabetes
US5789401A (en) * 1997-08-08 1998-08-04 Nutrition 21 High-dose chromium/biotin treatment of type II diabetes
GB9815177D0 (en) * 1998-07-13 1998-09-09 King S College London Treatment of skin disorders
US6680391B2 (en) 1998-07-13 2004-01-20 Btg International Limited Treatment of skin conditions
GB2370989A (en) 2001-01-16 2002-07-17 Btg Int Ltd Piperine analogues for the treatment of skin conditions
WO2000015051A1 (en) * 1998-09-14 2000-03-23 Interhealth Nutraceuticals, Inc. Hydroxycitric acid compositions
IL141967A0 (en) 1998-09-17 2002-03-10 Akesis Pharm Inc Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
US6376549B1 (en) 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
US6086888A (en) * 1998-12-22 2000-07-11 Bmb Patent Holding Corporation Analgesic compositions from sweet bell peppers and methods of use thereof
US6054585A (en) * 1998-12-23 2000-04-25 Sabinsa Corporation Process for making high purity piperine for nutritional use
US6534086B1 (en) * 2000-03-06 2003-03-18 Metagenics, Inc. Composition and method for treatment of inflammation and pain in mammals
US6258846B1 (en) * 1999-06-01 2001-07-10 Drugtech Corporation Nutritional supplements
US7112609B2 (en) * 1999-06-01 2006-09-26 Drugtech Corporation Nutritional supplements
US6187333B1 (en) 1999-09-20 2001-02-13 Diabex, Inc. Method for treating, controlling, and preventing diabetes mellitus
US20030236300A1 (en) * 1999-10-27 2003-12-25 Yale University Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
US6849645B2 (en) * 2000-05-19 2005-02-01 Sabinsa Corporation Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
EP1296682A4 (de) * 2000-06-28 2004-11-10 Bakulesh Mafatlal Khamar Chemosensibilisator
CN100420440C (zh) * 2000-06-28 2008-09-24 龟甲万株式会社 抗变态反应剂、含有它的药品、食品或化妆品及它们的制备方法
AU2001287743A1 (en) * 2000-09-20 2002-04-02 R.P. Scherer Gmbh And Co. Kg Oral dosage forms of boswellia extracts
JP4858889B2 (ja) * 2000-10-20 2012-01-18 有限会社大長企画 栄養剤、消化器剤
US6576253B2 (en) 2000-12-05 2003-06-10 Pbm Pharmaceuticals, Inc. Food bars containing nutritional supplements
US6579866B2 (en) * 2000-12-28 2003-06-17 Mccleary Larry Composition and method for modulating nutrient partitioning
US20060062864A1 (en) * 2000-12-28 2006-03-23 Mccleary Edward L Weight loss composition and method
US20040043013A1 (en) 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
IT1320180B1 (it) 2000-12-29 2003-11-26 Hunza Di Marazzita Maria Carme Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e
WO2002060864A1 (en) * 2001-01-30 2002-08-08 Sabinsa Corporation Process of obtaining compositions of stable lutein and lutein derivatives
WO2002090515A2 (en) * 2001-05-04 2002-11-14 Theralife, Inc. Compositions and methods for reducing cytotoxicity and inhibiting angiogenesis
US20030068391A1 (en) * 2001-10-04 2003-04-10 Harris Dennis H. Ingestible nerve and circulatory nutritional formulation
US20030099626A1 (en) * 2001-11-20 2003-05-29 Health Education Corporation Nutrient absorption enhancing compositions and methods
AU2002366588A1 (en) * 2001-12-13 2003-06-23 Council Of Scientific And Industrial Research Bioavailability enhancing activity of zingiber officinale linn and its extracts/fractions thereof
AU2003209674A1 (en) * 2002-03-12 2003-09-22 Council Of Scientific And Industrial Research Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
GB2403411B (en) * 2002-04-04 2006-04-12 Bakulesh Mafatlal Khamar Pharmaceutical compositions containing antiretroviral protease inhibitor with improved bioavailability
US6979468B1 (en) 2002-12-06 2005-12-27 Sirius Laboratories Oral composition and method for the treatment of inflammatory cutaneous disorders
EP1587521A1 (de) * 2003-01-30 2005-10-26 Council of Scientific and Industrial Research Bioverfügbarkeit erhöhende aktiviteit von carum carvi extrakten und deren fraktionen
US7160565B2 (en) * 2003-03-31 2007-01-09 Breakthru Products, Llc Hydration beverage and method of delivering nutrients
US7119075B2 (en) * 2003-03-31 2006-10-10 Council Of Scientific And Industrial Research Use of herbal agents for potentiation of bioefficacy of anti infectives
JP4589126B2 (ja) 2003-03-31 2010-12-01 カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ 抗感染剤の生物学的有効性に影響を及ぼすためのクミン（ｃｕｍｉｎｕｍｃｙｍｉｎｕｍ）抽出物及びピペリンの使用
US8703209B2 (en) * 2003-06-17 2014-04-22 Edward Larry McCleary Composition and method for modulating hydrogen ion physiology
AU2004257756A1 (en) * 2003-07-10 2005-01-27 Carl A. Forest Foods, beverages, condiments, spices and salad dressings with specialized supplements
JP4012894B2 (ja) * 2003-09-17 2007-11-21 レキオファーマ株式会社 ウコン含有組成物
JP4797363B2 (ja) * 2003-11-13 2011-10-19 大正製薬株式会社 高血圧改善剤
US20080160086A1 (en) * 2004-02-19 2008-07-03 Scepter Holdings, Inc. Delivery Systems For Calcium
US20050276839A1 (en) * 2004-06-10 2005-12-15 Rifkin Calman H Appetite satiation and hydration beverage
DE502005001780D1 (de) * 2005-02-24 2007-12-06 Pm Int Ag Nahrungsergänzungsmittelpräparat-Set
US20060198906A1 (en) * 2005-03-07 2006-09-07 Sami Labs Limited Compositions and Method to Increase Serum Levels of HDL cholesterol and Lower the Risk of Cardiovascular Disease
US8021701B1 (en) 2005-04-13 2011-09-20 Perry Stephen C Composition to retard the onset of symptoms of alzheimer's disease
FR2887748B1 (fr) * 2005-06-29 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires.
FR2887749B1 (fr) * 2005-06-29 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires
DE102005043986A1 (de) * 2005-09-14 2007-04-05 Mark Warnecke Zusatznahrungsmittel
US20070077220A1 (en) * 2005-09-30 2007-04-05 Ramirez Jose E Stable ascorbic acid compositions
US20070116852A1 (en) * 2005-11-22 2007-05-24 Josef Schnatmann Cattle feed preparation
US20070178058A1 (en) * 2006-02-02 2007-08-02 Ramirez Jose E Methods of using stable ascorbic acid compositions
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
ES2579229T3 (es) 2007-03-13 2016-08-08 Jds Therapeutics, Llc Procedimientos y composiciones para la liberación sostenida de cromo
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
EP2011495A1 (de) * 2007-07-03 2009-01-07 Sygnis Bioscience GmbH & Co. KG Verwendungen von Piperin und Derivaten daraus zur Behandlung neurologischer Leiden
US7877929B2 (en) 2007-08-04 2011-02-01 Rezzorb, Llc Method and apparatus for reducing fertilizer use in agricultural operations
US20090062231A1 (en) * 2007-08-31 2009-03-05 O'mara Ann Marie Appetite Suppressant Composition and Method of Appetite Suppression
US20090297622A1 (en) * 2008-01-01 2009-12-03 Khorshid Faten A Separation and formulation of bioactive fraction and subfraction from camel urine work as anticancer agent
KR101078376B1 (ko) * 2009-02-02 2011-10-31 연세대학교 산학협력단 피페린 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 비만 예방 및 치료용 조성물
US8247435B2 (en) * 2009-02-19 2012-08-21 Thornthwaite Jerry T Formulations for treating human and animal diseases
US20100273207A1 (en) * 2009-04-24 2010-10-28 Raymond Langley Methods for Diagnosis of Sepsis and Risk of Death
ES2547466T3 (es) 2009-06-17 2015-10-06 Fatin A. Khorshid Separación y formulación de fracción bioactiva y trabajo de subfracción de orina de camello como agente anticáncer
EP2289528A1 (de) 2009-07-21 2011-03-02 DSM IP Assets B.V. Neuartige nutrazeutische Zusammensetzungen mit schwarzem Pfeffer oder Bestandteilen zur Verbesserung der mentalen Leistung
WO2011010214A1 (en) * 2009-07-23 2011-01-27 Cadila Pharmaceuticals Ltd. Pharmaceutical composition of rifampicin
JP2011073973A (ja) * 2009-09-29 2011-04-14 Shiseido Co Ltd 更年期のための疲労改善組成物
GB201002314D0 (en) * 2010-02-11 2010-03-31 Gomez Richard N C Dietary supplement composition
GB201002318D0 (en) * 2010-02-11 2010-03-31 Gomez Richard N C Dietary supplement composition
JP2012051833A (ja) * 2010-08-31 2012-03-15 Toyo Shinyaku Co Ltd 血流改善用組成物
JP2012070726A (ja) * 2010-08-31 2012-04-12 Toyo Shinyaku Co Ltd バイオアベイラビリティを高めた美容食品用組成物
KR101281827B1 (ko) * 2011-03-25 2013-07-03 (주)풀무원홀딩스 피페린을 유효성분으로 포함하는 인삼 사포닌 흡수 촉진용 조성물
US8840938B2 (en) * 2011-04-13 2014-09-23 W. Matthew Warnock Bioavailability enhancing composition
CA2855469A1 (en) * 2011-04-22 2012-10-26 Paul Joseph FAERSTEIN Compositions and methods for nutritional supplementation
ES2739194T3 (es) 2012-01-19 2020-01-29 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Formulación y método para aumentar la biodisponibilidad oral de fármacos
US10485258B2 (en) 2012-05-01 2019-11-26 Board Of Trustees, Rutgers, The State University Of New Jersey Production of enriched products
JP6760710B2 (ja) * 2013-09-13 2020-09-23 大正製薬株式会社 飲料
EP3280272B1 (de) 2013-11-01 2021-05-26 Rutgers, The State University of New Jersey Pflanzenextrakte aus der familie moringaceae und verfahren zur herstellung
CA2928752A1 (en) 2013-11-01 2015-05-07 Rutgers, The State University Of New Jersey Extracts from plants of the moringaceae family and methods of making
AU2017217466A1 (en) 2016-02-11 2018-08-23 Nutrition 21, Llc Chromium containing compositions for improving health and fitness
IT201600128994A1 (it) * 2016-12-20 2018-06-20 Inpha Duemila Srl Formulazioni per uso nel trattamento dell’endometriosi e dei disturbi ad essa associati
CA3063174A1 (en) 2017-05-12 2018-11-15 Innovus Pharmaceuticals, Inc. Therapeutic methods and compositions
ES2960296T3 (es) 2017-07-11 2024-03-04 Aquanova Ag Solubilizado con curcumina y boswelia y xantohumol
EP3679022A1 (de) 2017-10-14 2020-07-15 Cipla Limited Verfahren zur herstellung von piperin
US10500199B2 (en) 2017-12-01 2019-12-10 Innovus Pharmaceuticals, Inc. Nutritional supplement for increasing cognitive functions
US10758505B2 (en) * 2017-12-01 2020-09-01 Innovus Pharmaceuticals, Inc. Therapeutic compositions and methods
US10864205B2 (en) * 2017-12-01 2020-12-15 Innovus Pharmaceuticals, Inc. Nutritional supplement for improving sexual health in men and women
US20190167699A1 (en) 2017-12-01 2019-06-06 Innovus Pharmaceuticals, Inc. Prostate function support formula
DE102018101778A1 (de) * 2018-01-26 2019-08-01 Lts Lohmann Therapie-Systeme Ag Mehrschichtiger Oraler Dünnfilm
HRP20231146T1 (hr) 2018-07-11 2024-01-05 Aquanova Ag Solubilizat ksantohumola
US20200115663A1 (en) * 2018-10-16 2020-04-16 Golden Spice Liquors LLC Beverage compositions and methods of making and using the same
US10849948B2 (en) 2019-04-16 2020-12-01 The Procter & Gamble Company Supplement for menopause
FR3097122B1 (fr) * 2019-06-11 2021-06-18 Valbiotis Melange d’extraits de plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l’intestin
IL271778A (en) 2019-12-31 2021-06-30 Ichilov Tech Ltd Methods for treating atopic dermatitis
AU2021281159B2 (en) * 2020-05-29 2024-09-19 Vedicinals India Private Limited A composition for management of COVID-19 and associated disorders
JP2020196770A (ja) * 2020-09-16 2020-12-10 株式会社東洋新薬 血流改善剤
JP7162357B2 (ja) * 2020-10-02 2022-10-28 株式会社山田養蜂場本社 桂皮酸誘導体の吸収促進剤
JP2021066739A (ja) * 2021-01-28 2021-04-30 株式会社東洋新薬 血流改善組成物
MX2024000933A (es) * 2021-07-22 2024-02-08 Nicoventures Trading Ltd Composiciones que comprenden constituyentes, derivados o extracto de cannabis.
EP4453180A4 (de) 2021-12-22 2026-02-18 The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo Nomadische bakterien und verwendungen davon
CN116268431B (zh) * 2022-12-22 2025-06-27 北京康比特体育科技股份有限公司 一种改善或促进乳清蛋白吸收的组合物及其应用
CN116602405B (zh) * 2023-05-18 2024-05-28 北京康比特体育科技股份有限公司 含黑胡椒提取物的组合物在制备促进肌肉蛋白质合成及缓解和/或消除炎症的产品中的应用
CN117958426A (zh) * 2024-01-31 2024-05-03 武汉森澜生物科技有限公司 含荜茇和黑胡椒的营养素生物利用度促进剂和制备方法
JP7847885B2 (ja) * 2024-02-29 2026-04-20 株式会社三旺コーポレーション 経口用組成物
CN118766020A (zh) * 2024-08-21 2024-10-15 馨辰生物(广东)有限公司 润肠通便饮品及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284657A (en) * 1980-01-09 1981-08-18 Kraf, Inc. Fluidized oleoresin compositions
US5744161A (en) * 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer

Also Published As

Publication number Publication date
US5744161A (en) 1998-04-28
PT810868E (pt) 2002-02-28
CA2247467C (en) 2007-05-29
JPH11500725A (ja) 1999-01-19
ES2161914T3 (es) 2001-12-16
DE69522477T2 (de) 2002-05-29
US5972382A (en) 1999-10-26
GR3036711T3 (en) 2001-12-31
AU4128796A (en) 1996-09-11
EP0810868B1 (de) 2001-08-29
DK0810868T3 (da) 2001-11-26
EP0810868A1 (de) 1997-12-10
DE69522477D1 (de) 2001-10-04
EP0810868A4 (de) 1998-11-25
CA2247467A1 (en) 1996-08-29
WO1996025939A1 (en) 1996-08-29
JP3953513B2 (ja) 2007-08-08

Similar Documents

Publication Publication Date Title
DE69522477D1 (de) Verwendung von piperine zur verbesserung der gastrointestinalen absorption
AU8581991A (en) Mercaptoacetylamide derivatives as inhibitors of enkephalinase and ACE, and processes for their production
TW352384B (en) Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
DE69202307D1 (de) Kryogenisches Rektifikationsverfahren zur Herstellung von gereinigtem Argon.
HUT65278A (en) Process for producing pyrido-, pyrrolo-, thiazino-, oxazino- and pyrazino-benzazepine derivatives and pharmaceutical preparations containing them
MY116928A (en) Purification of crude acrylic acid by crystallization
ZA961074B (en) Chiral Methylphenyloxazolidinones.
DE69407272D1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
SI0785948T1 (en) Analogs of keratinocyte growth factor
IT1214587B (it) Metodo per la produzione diprodotti cristallini puri.
UA49884C2 (uk) ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
DE68913907D1 (de) Methode zur Behandlung des interstitiellen Blasenentzündung.
YU47100A (sh) Novi derivati dihidroksiheksanoinske kiseline
UA35607C2 (uk) Похідні оксазолідинонкарбонової кислоти, спосіб їх одержання, фармацевтична композиція і спосіб її одержання
IL89352A0 (en) Milk anti-hypertensive factor,method for the production thereof and pharmaceutical compositions containing the same
MXPA05012209A (es) Metodo de racemizacion de (s)-(+)- y (r)-(-)-10, 11-dihidro-10 -hidroxi- 5h-dibenz/b, f/azepin-5- carboxamida y mezclas opticamente enriquecidas de las mismas.
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
TW363973B (en) Stable polypeptide composition and method of preparation the same
AU2003271811A1 (en) Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same
BG104034A (en) Method for the preparation of pharmaceutical compounds of antidepressive effect and against the parkinson syndrome effect
ATE181507T1 (de) Harpagosid-angereicherter extrakt aus harpagophytum procumbens und verfahren zu seiner herstellung
FI950892L (fi) Entsymaattinen asymmetrinen pelkistysmenetelmä 4-H-tieno-(2,3-6) tiopyraanijohdannaisten tuottamiseksi
EP0770626A3 (de) Verfahren zur Reinigung von Thrombomodulin
IL135364A0 (en) Vitamin d derivatives, processes for the production thereof and for producing pharmaceutical compositions containing the same
DE3678139D1 (de) Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification